Logo
Sunekos Performa

Sunekos Performa

Sunekos

Injectable aesthetic / skin‑booster
  • CE‑marked Class III Medical Device (as per vendor / distributor declarations). :contentReference[oaicite:30]{index=30}
Mesotherapy / ECM\u2011regeneration injectable

Description

Sunekos Performa is a premixed injectable solution combining low‑molecular‑weight hyaluronic acid with a patented amino acid complex (HY6AA). It is designed for skin biostimulation — to restore the extracellular matrix (ECM), stimulate collagen and elastin production, improve skin elasticity, hydration, and overall skin quality, rather than act as a volumizing dermal filler. It is intended for aesthetic use by qualified professionals on face, neck, décolletage, hands and other areas showing signs of skin aging or laxity. :contentReference[oaicite:0]{index=0}

Bnefits

  • Stimulates production of collagen (including types of reticular collagen) and elastin, improving ECM structure. :contentReference[oaicite:1]{index=1}
  • Improves skin elasticity, firmness, hydration and skin texture. :contentReference[oaicite:2]{index=2}
  • Reduces appearance of fine lines and wrinkles, and may improve skin laxity. :contentReference[oaicite:3]{index=3}
  • Suitable for delicate areas (e.g. periocular, neck, décolletage, hands) when used by trained professionals. :contentReference[oaicite:4]{index=4}
  • Pre‑mixed ready‑to‑use injectable formulation for ease of administration. :contentReference[oaicite:5]{index=5}

Indications

  • Wrinkles and fine lines (superficial to moderate) on face, periocular area, neck, décolletage, hands. :contentReference[oaicite:6]{index=6}
  • Skin laxity or decreased elasticity / firmness due to aging or photo‑aging. :contentReference[oaicite:7]{index=7}
  • Skin quality improvement: hydration, texture, elasticity, ECM regeneration for mature or photo‑damaged skin. :contentReference[oaicite:8]{index=8}
  • Volume restoration in areas with mild volume loss or skin depressions (non‑volumizing but scaffold support). :contentReference[oaicite:9]{index=9}

Composition

  • Low‑molecular‑weight hyaluronic acid (non–crosslinked) — HA (35 mg per 3.5 ml vial as per some vendor data) :contentReference[oaicite:10]{index=10}
  • Amino acid complex HY6AA: Glycine, L‑Proline, L‑Lysine, L‑Leucine, L‑Valine, L‑Alanine. :contentReference[oaicite:11]{index=11}
  • Sterile aqueous vehicle / water for injection (standard for injectable HA + AA solutions) :contentReference[oaicite:12]{index=12}

Formulation

  • Premixed injectable vial (ready to use) — 2 × 3.5 ml vials per pack. :contentReference[oaicite:13]{index=13}
  • Low‑viscosity non‑crosslinked HA + amino‑acid solution intended for intradermal / mesotherapy injections. :contentReference[oaicite:14]{index=14}

Packaging

  • Box containing 2 sterile vials of 3.5 ml each (total 7.0 ml), intended for professional aesthetic use. :contentReference[oaicite:15]{index=15}

Usage

  • Must be administered by a qualified medical professional trained in aesthetic injection techniques under aseptic conditions. :contentReference[oaicite:16]{index=16}
  • Injection into medium–deep dermis; for face / fine lines: fine needle (e.g., 30G × 12 mm) or cannula (27–30G) for deeper or larger areas. :contentReference[oaicite:17]{index=17}
  • Typical treatment protocol: 3–4 sessions spaced approximately 2 weeks apart (some protocols may combine with other treatments). :contentReference[oaicite:18]{index=18}
  • Areas commonly treated include full face, periocular area, neck, décolletage, hands. :contentReference[oaicite:19]{index=19}

Contraindications

  • Hypersensitivity to hyaluronic acid or amino acid components. :contentReference[oaicite:22]{index=22}
  • Active skin inflammation, infection, acne, herpes or compromised skin integrity at injection site. :contentReference[oaicite:23]{index=23}
  • Pregnancy and breastfeeding (safety not established / many providers contraindicate). :contentReference[oaicite:24]{index=24}
  • Bleeding disorders or use of anticoagulant therapy (risk of bruising / hematoma). :contentReference[oaicite:25]{index=25}

Adverse Effects

  • Temporary redness, swelling, mild bruising or tenderness at injection site — common and generally resolving in days. :contentReference[oaicite:26]{index=26}
  • Possible mild discomfort during or after injection; rare risk of localized nodules or irregularities if administered improperly. :contentReference[oaicite:27]{index=27}

Storage Conditions

  • Store unopened vials at controlled room temperature (protect from extreme heat / freezing / direct sunlight). :contentReference[oaicite:28]{index=28}
  • Use immediately under sterile conditions; do not reuse or re‑sterilize vials after opening. :contentReference[oaicite:29]{index=29}

Duration

Often 3\u20134 sessions over several weeks; maintenance as determined by clinician (not strictly defined). :contentReference[oaicite:20]{index=20}

Onset

Initial hydration/texture improvement may be visible soon after treatment; more sustained ECM / elasticity improvements reported over weeks. :contentReference[oaicite:21]{index=21}

Browse more Injectable aesthetic / skin\u2011booster

Top Treatments

Top Cities in the UK